# Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

> **NCT05887700** · — · RECRUITING · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 145 (estimated)

## Conditions studied

- Atrial Septal Defect

## Interventions

- **DEVICE:** CeraFlex™ Atrial Septal Defect (ASD) Closure System

## Key facts

- **NCT ID:** NCT05887700
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05887700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05887700, "Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05887700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*